# Pharmacokinetics of XueBiJing in Patients With Sepsis

> **NCT03475732** · NA · COMPLETED · sponsor: **Southeast University, China** · enrollment: 35 (actual)

## Conditions studied

- Sepsis
- Septic Shock
- Community Acquired Pneumonia

## Interventions

- **DRUG:** XueBiJing injection

## Key facts

- **NCT ID:** NCT03475732
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-18
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475732, "Pharmacokinetics of XueBiJing in Patients With Sepsis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03475732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*